THE NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES TWO ARTICLES ON TROGARZO™

Aug 15, 2018
PDF Version
Supporting Materials:

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that results from the phase III clinical trial used to obtain FDA approval for TrogarzoTM (ibalizumab-uiyk) injection in the United States were published in the most recent edition of The New England Journal of Medicine (NEJM).